UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(MARK
ONE)
☒ QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the quarter ended March 31, 2024
☐ TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the transition period from to
Commission
file number: 001-41718
ESH
ACQUISITION CORP.
(Exact
Name of Registrant as Specified in Its Charter)
Delaware | | 87-4000684 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
228
Park Ave S, Suite 89898
New
York, NY 10003
(Address
of principal executive offices)
212-287-5022
(Issuer’s
telephone number)
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Units | | ESHAU | | The Nasdaq Global Market |
Class A shares | | ESHA | | The Nasdaq Global Market |
Rights | | ESHAR | | The Nasdaq Global Market |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| Emerging growth company | ☒ |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐
As
of May 20, 2024, there were 11,787,500 shares of Class A common stock, $0.0001 par value and 2,875,000 shares of Class B common stock,
$0.0001 par value, issued and outstanding.
ESH
ACQUISITION CORP.
FORM
10-Q FOR THE QUARTER ENDED MARCH 31, 2024
TABLE
OF CONTENTS
PART
I - FINANCIAL INFORMATION
Item
1. Interim Financial Statements
ESH
ACQUISITION CORP.
CONDENSED
BALANCE SHEETS
| |
March 31, 2024 | | |
December 31, 2023 | |
| |
(Unaudited) | | |
| |
ASSETS | |
| | |
| |
Current assets | |
| | |
| |
Cash | |
$ | 1,820,447 | | |
$ | 1,879,227 | |
Due from Sponsor | |
| 10,136 | | |
| 25,796 | |
Prepaid expenses | |
| 8,209 | | |
| 18,082 | |
Short-term prepaid insurance | |
| 281,681 | | |
| 281,681 | |
Total Current Assets | |
| 2,120,473 | | |
| 2,204,786 | |
| |
| | | |
| | |
Long-term prepaid insurance | |
| 57,119 | | |
| 127,539 | |
Investments held in Trust Account | |
| 121,565,683 | | |
| 120,000,366 | |
TOTAL ASSETS | |
$ | 123,743,275 | | |
$ | 122,332,691 | |
| |
| | | |
| | |
LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION, AND STOCKHOLDERS’ EQUITY | |
| | | |
| | |
Current liabilities | |
| | | |
| | |
Accounts payable and accrued expenses | |
$ | 166,788 | | |
$ | 107,954 | |
Franchise tax payable | |
| 162,961 | | |
| 112,343 | |
Income taxes payable | |
| 981,484 | | |
| 819,453 | |
TOTAL LIABILITIES | |
| 1,311,233 | | |
| 1,039,750 | |
| |
| | | |
| | |
Commitments and Contingencies | |
| | | |
| | |
| |
| | | |
| | |
COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION | |
| | | |
| | |
Class A common stock subject to possible redemption, 11,500,000 shares at redemption value of approximately $10.47 and $10.35 per share at March 31, 2024 and December 31, 2023, respectively | |
| 120,421,238 | | |
| 119,068,570 | |
| |
| | | |
| | |
STOCKHOLDERS’ EQUITY | |
| | | |
| | |
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at March 31, 2024 and December 31, 2023 | |
| — | | |
| — | |
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 287,500 issued and outstanding (excluding 11,500,000 shares subject to possible redemption) at March 31, 2024 and December 31, 2023 | |
| 28 | | |
| 28 | |
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 2,875,000 issued and outstanding at March 31, 2024 and December 31, 2023 | |
| 288 | | |
| 288 | |
Additional paid-in capital | |
| — | | |
| 297,488 | |
Retained earnings | |
| 2,010,488 | | |
| 1,926,567 | |
TOTAL STOCKHOLDERS’ EQUITY | |
| 2,010,804 | | |
| 2,224,371 | |
TOTAL LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION, AND STOCKHOLDERS’ EQUITY | |
$ | 123,743,275 | | |
$ | 122,332,691 | |
The
accompanying notes are an integral part of the unaudited condensed financial statements.
ESH
ACQUISITION CORP.
CONDENSED
STATEMENTS OF OPERATIONS
(UNAUDITED)
| |
Three Months Ended March 31, | |
| |
2024 | | |
2023 | |
General and administrative expenses | |
$ | 213,567 | | |
$ | 2,867 | |
Franchise tax expense | |
| 50,618 | | |
| — | |
Loss from operations | |
| (264,185 | ) | |
| (2,867 | ) |
| |
| | | |
| | |
Other income: | |
| | | |
| | |
Interest earned on investments held in Trust Account | |
| 1,565,317 | | |
| — | |
Total other income | |
| 1,565,317 | | |
| — | |
| |
| | | |
| | |
Income (loss) before provision for income taxes | |
| 1,301,132 | | |
| (2,867 | ) |
Provision for income taxes | |
| (162,031 | ) | |
| — | |
Net income (loss) | |
$ | 1,139,101 | | |
$ | (2,867 | ) |
| |
| | | |
| | |
Basic and diluted weighted average shares outstanding, Class A common stock | |
| 11,787,500 | | |
| — | |
Basic and diluted net income per share | |
$ | 0.08 | | |
$ | — | |
| |
| | | |
| | |
Basic and diluted weighted average shares outstanding, Class B common stock(1) | |
| 2,875,000 | | |
| 2,500,000 | |
Basic and diluted net income (loss) per share | |
$ | 0.08 | | |
$ | (0.00 | ) |
(1) | Excluded up to 375,000 shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (Note 5). |
The
accompanying notes are an integral part of the unaudited condensed financial statements.
ESH
ACQUISITION CORP.
CONDENSED
STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(UNAUDITED)
FOR
THE THREE MONTHS ENDED MARCH 31, 2024
|
|
Class A Common Stock |
|
|
Class B Common Stock |
|
|
Additional Paid-in |
|
|
Retained |
|
|
Total Stockholders’ |
|
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Earnings |
|
|
Equity |
|
Balance — January 1, 2024 |
|
|
287,500 |
|
|
$ |
28 |
|
|
|
2,875,000 |
|
|
$ |
288 |
|
|
$ |
297,488 |
|
|
$ |
1,926,567 |
|
|
$ |
2,224,371 |
|
Remeasurement of Class A common stock subject to possible redemption |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(297,488 |
) |
|
|
(1,055,180 |
) |
|
|
(1,352,668 |
) |
Net income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,139,101 |
|
|
|
1,139,101 |
|
Balance – March 31, 2024 (unaudited) |
|
|
287,500 |
|
|
$ |
28 |
|
|
|
2,875,000 |
|
|
$ |
288 |
|
|
$ |
— |
|
|
$ |
2,010,488 |
|
|
$ |
2,010,804 |
|
FOR
THE THREE MONTHS ENDED MARCH 31, 2023
| |
Class A Common Stock | | |
Class B Common Stock | | |
Additional
Paid-in | | |
Accumulated | | |
Total Stockholders’ | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Equity | |
Balance — January 1, 2023(1) | |
| — | | |
$ | — | | |
| 2,875,000 | | |
$ | 288 | | |
$ | 24,712 | | |
$ | (20,332 | ) | |
$ | 4,668 | |
Net loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (2,867 | ) | |
| (2,867 | ) |
Balance – March 31, 2023(1) (unaudited) | |
| — | | |
$ | — | | |
| 2,875,000 | | |
$ | 288 | | |
$ | 24,712 | | |
$ | (23,199 | ) | |
$ | 1,801 | |
(1) | Included up to 375,000 shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (Note 5). |
The
accompanying notes are an integral part of the unaudited condensed financial statements.
ESH
ACQUISITION CORP.
CONDENSED
STATEMENTS OF CASH FLOWS
(UNAUDITED)
| |
Three Months Ended March 31, | |
| |
2024 | | |
2023 | |
Cash Flows from Operating Activities: | |
| | |
| |
Net income (loss) | |
$ | 1,139,101 | | |
$ | (2,867 | ) |
Adjustments to reconcile net income (loss) to net cash
provided by (used in) operating activities: | |
| | | |
| | |
Interest earned on investments held in Trust Account | |
| (1,565,317 | ) | |
| — | |
Changes in operating assets and liabilities: | |
| | | |
| | |
Prepaid expenses and other current assets | |
| 9,873 | | |
| — | |
Long-term prepaid insurance | |
| 70,420 | | |
| — | |
Due from Sponsor | |
| 15,660 | | |
| — | |
Accounts payable and accrued expenses | |
| 137,717 | | |
| (2,851 | ) |
Franchise tax payable | |
| 50,618 | | |
| — | |
Income taxes payable | |
| 162,031 | | |
| — | |
Net cash provided
by (used in) operating activities | |
| 20,103 | | |
| (5,718 | ) |
| |
| | | |
| | |
Cash Flows from Financing Activities: | |
| | | |
| | |
Payment of offering costs | |
| (78,883 | ) | |
| (8,000 | ) |
Net cash used in financing activities | |
| (78,883 | ) | |
| (8,000 | ) |
| |
| | | |
| | |
Net Change in Cash | |
| (58,780 | ) | |
| (13,718 | ) |
Cash – Beginning of period | |
| 1,879,227 | | |
| 44,963 | |
Cash – End of period | |
$ | 1,820,447 | | |
$ | 31,245 | |
| |
| | | |
| | |
Non-cash investing and financing activities: | |
| | | |
| | |
Offering costs included in accrued expenses | |
$ | — | | |
$ | 30,000 | |
The
accompanying notes are an integral part of the unaudited condensed financial statements.
ESH ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2024
(UNAUDITED)
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
ESH Acquisition Corp. (the “Company”)
was incorporated as a Delaware corporation on November 17, 2021. The Company was incorporated for the purpose of effecting a merger, capital
stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities
that the Company has not yet identified (the “Initial Business Combination”).
As of March 31, 2024, the Company had not commenced
any operations. All activity for the period from November 17, 2021 (inception) through March 31, 2024 relates to the Company’s formation
and the initial public offering (the “IPO”), which is described below, and subsequent to the IPO, identifying a target
company for the Initial Business Combination. The Company will not generate any operating revenues until after the completion of the Initial
Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds held
in the Trust Account (defined below). The Company has selected December 31 as its fiscal year end.
The registration statement for the Company’s
IPO was declared effective on June 13, 2023. On June 16, 2023, the Company consummated the IPO of 11,500,000 Units (the “Units”
and, with respect to the shares of Class A common stock included in the Units being offered, the “Public Shares”),
which includes the full exercise by the underwriters of their over-allotment option in the amount of 1,500,000 Units, at $10.00 per Unit,
generating gross proceeds of $115,000,000 which is described in Note 3.
Simultaneously with the closing of the IPO, the
Company consummated the sale of 7,470,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private
Placement Warrant, in a private placement to the Company’s Sponsor, ESH Sponsor LLC, a limited liability company, which is an affiliate
of members of the Board of Directors and management team (the “Sponsor”), and I-Bankers Securities, Inc. (“I-Bankers”)
and Dawson James (“Dawson James”), the representative of the underwriters of the IPO, generating gross proceeds of
$7,470,000, which is described in Note 4.
Transaction costs amounted to $5,368,092, consisting
of $2,300,000 of cash underwriting discount, $2,239,466 fair value of Representative Shares, and $828,626 of other offering costs.
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of its IPO and the sale of Private Placement Warrants, although substantially
all of the net proceeds are intended to be applied generally toward consummating the Initial Business Combination. The Company’s
Initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of
the net assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes and excluding
the amount of any Marketing Fee, as defined in Note 6, held in Trust Account) at the time the Company signs a definitive agreement in
connection with the Initial Business Combination. However, the Company will only complete the Initial Business Combination if the post-transaction
company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise is not required to register as an
investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”).
Following the closing of the IPO on June 16, 2023,
an amount of $116,725,000 ($10.15 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement
Warrants was placed in the Trust Account (“Trust Account”) with Continental Stock Transfer & Trust Company acting
as trustee and invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment
Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under
the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier
of (i) the completion of the Initial Business Combination or (ii) the distribution of the Trust Account as described below.
The Company will provide holders of the Company’s
outstanding Public Shares sold in the IPO (the “Public Stockholders”) with the opportunity to redeem all or a portion
of their Public Shares upon the completion of the Initial Business Combination either (i) in connection with a stockholder meeting called
to approve the Initial Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder
approval of the Initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public
Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially
anticipated to be $10.15 per Public Share). The per-share amount to be distributed to Public Stockholders who redeem their Public Shares
will not be reduced by the Marketing Fee the Company will pay to the underwriters (as discussed in Note 6).
ESH ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2024
(UNAUDITED)
The Public Shares are recorded at a
redemption value and classified as temporary equity in accordance with Financial Accounting Standards Board
(“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing
Liabilities from Equity” (“ASC 480”). The Company will proceed with an Initial Business Combination if the
Company has net tangible assets of at least $5,000,001 upon such consummation of the Initial Business Combination and a majority of
the shares voted are voted in favor of the Initial Business Combination. If a stockholder vote is not required by applicable law or
stock exchange requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company
will, pursuant to the amended and restated certificate of incorporation adopted by the Company upon the consummation of the IPO (the
“Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules
of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to
completing an Initial Business Combination. If, however, a stockholder approval of the transactions is required by law, or the
Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction
with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public
Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If
the Company seeks stockholder approval in connection with an Initial Business Combination, the holders of the Founder Shares prior
to the IPO (the “Initial Stockholders”) agreed to vote their Founder Shares (as defined in Note 5) and any Public
Shares purchased during or after the IPO in favor of the Initial Business Combination. In addition, the Initial Stockholders agreed
to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of an
Initial Business Combination. In addition, the Company agreed not to enter into a definitive agreement regarding an Initial Business
Combination without the prior consent of the Sponsor.
Notwithstanding the foregoing, the Amended and
Restated Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other
person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act),
will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent
of the Company.
The Initial Stockholders will agree not to propose
an amendment to the Certificate of Incorporation (A) in a manner that would affect the substance or timing of the Company’s obligation
to redeem 100% of the Public Shares if the Company does not complete an Initial Business Combination within the time frame described below
or (B) with respect to any other material provision relating to the rights of holders of Public Shares or pre-Initial Business Combination
activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares upon approval of any
such amendment.
The Company will have only the Combination Period,
or until December 16, 2024, to complete the Initial Business Combination.
On July 20, 2023, the Company issued a press release
announcing that, on July 21, 2023, the Units would no longer trade, and that the Company’s common stock and rights, which together
comprise the Units will commence trading separately. The common stock and rights will be listed on the Nasdaq Global Market and trade
with the ticker symbols “ESHA,” and “ESHAR,” respectively. This is a mandatory and automatic separation, and no
action was required by the holders of Units.
If the Company is unable to complete an Initial
Business Combination within 18 months from the closing of the IPO (the “Combination Period”), the Company will (i)
cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days
thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust
Account, including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses)
divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights
as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly
as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Board of Directors, dissolve
and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements
of other applicable law. There will be no redemption rights or liquidating distributions with respect to the warrants, which will expire
worthless if the Company fails to complete the Initial Business Combination within the Combination Period.
ESH ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2024
(UNAUDITED)
The Initial Stockholders will not be entitled
to liquidation rights with respect to the Founder Shares if the Company fails to complete an Initial Business Combination within the Combination
Period. However, if the Initial Stockholders should acquire Public Shares in or after the IPO, they will be entitled to liquidating distributions
from the Trust Account with respect to such Public Shares if the Company fails to complete an Initial Business Combination within the
Combination Period. The underwriters will agree to waive their rights to the Marketing Fee (see Note 6) held in the Trust Account in the
event the Company does not complete an Initial Business Combination within the Combination Period and, in such event, such amounts will
be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the
event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including
Trust Account assets) will be only $10.15. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable
to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting
firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into
a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce
the amount of funds in the Trust Account to below the lesser of (i) $10.15 per Public Share and (ii) the actual amount per Public Share
held in the Trust Account due to reductions in the value of the trust assets as of the date of the liquidation of the Trust Account, in
each case including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise
and income taxes, less franchise and income taxes payable. This liability will not apply with respect to any claims by a third party or
Target that executed an agreement waiving any and all rights to seek access to the Trust Account (whether or not such agreement is enforceable)
or to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities
under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility
that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers
(other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which
the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies
held in the Trust Account.
Risks and Uncertainties
Management is currently evaluating the
impact of the current global economic uncertainty, rising interest rates, high inflation, high energy prices, supply chain
disruptions, the Israel-Hamas conflict and the Russia-Ukraine war (including the impact of any sanctions imposed in response
thereto) and has concluded that while it is reasonably possible that any of these events could have a negative effect on the
Company’s financial position, results of operations and/or search for a target company, the specific impact is not readily
determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not
include any adjustments that might result from the outcome of these uncertainties. The Company cannot at this time fully predict the
likelihood of one or more of the above events, their duration or magnitude, or the extent to which they may negatively impact the
Company’s business and its ability to complete an Initial Business Combination.
Going Concern Consideration
As of March 31, 2024, the Company had cash of
$1,820,447 and working capital of $809,240.
Until the consummation of an Initial Business
Combination, the Company will be using the funds held outside the Trust Account for identifying and evaluating target businesses, performing
due diligence on prospective target businesses, paying for travel expenditures, reviewing corporate documents and material agreements
of prospective target businesses, and structuring, negotiating and completing an Initial Business Combination.
In order to finance transaction costs in connection
with an Initial Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors
may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company
completes an Initial Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account
released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the
event that the Initial Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to
repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for
the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect
to such loans. The Working Capital Loans would either be repaid upon consummation of an Initial Business Combination, without interest,
or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post-Initial
Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of
March 31, 2024 and December 31, 2023, the Company had no borrowings under the Working Capital Loans.
In connection with the Company’s assessment
of going concern considerations in accordance with FASB Accounting Standards Update 2014-15, “Disclosures of Uncertainties about
an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company is unable to complete
an Initial Business Combination by December 16, 2024, then the Company will cease all operations except for the purpose of liquidating.
The date for mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue
as a going concern. Management plans to consummate an Initial Business Combination prior to the mandatory liquidation date. No adjustments
have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 16, 2024.
ESH ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2024
(UNAUDITED)
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited condensed financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”)
for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain
information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or
omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information
and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management,
the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are
necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
The accompanying unaudited condensed financial
statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on April 1, 2024. The
interim results for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for the year ending
December 31, 2024 or for any future periods.
Emerging Growth Company
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting
firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but
any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that
when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging
growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of the Company’s unaudited condensed financial statements with another public company which is neither an emerging growth company
nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential
differences in accounting standards used.
Use of Estimates
The preparation of the unaudited condensed financial
statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial
statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could
change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those
estimates.
Cash and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,820,447 and $1,879,227 of
cash as of March 31, 2024 and December 31, 2023, respectively, and no cash equivalents.
Investments Held in Trust Account
At March 31, 2024 and December 31, 2023, all of
the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. treasury securities. The
investments held in Trust Account are classified as trading securities. Trading securities are presented on the condensed balance
sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments
held in Trust Account are included in interest earned on investments held in Trust Account in the accompanying condensed statements
of operations. The estimated fair values of investments held in the Trust Account are determined using available market
information.
ESH ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2024
(UNAUDITED)
Fair Value of Financial Instruments
The fair value of the Company’s assets
and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurement,” approximates
the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature.
Fair value is defined as the price that would
be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement
date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives
the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the
lowest priority to unobservable inputs (Level 3 measurements). The Company’s financial instruments are classified as either Level
1, Level 2, or Level 3. These tiers include:
|
● |
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
|
|
|
|
● |
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
|
|
|
|
● |
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
Offering Costs
Offering costs consisted of legal,
accounting, and other costs incurred through the condensed balance sheet date that were directly related to the IPO. Upon completion
of the IPO, offering costs were allocated to the separable financial instruments issued in the IPO based on a relative fair value
basis, compared to total proceeds received. Offering costs allocated to the warrants were charged to equity. Offering costs
allocated to the Class A common stock were charged against the carrying value of Class A common stock subject to possible
redemption upon the completion of the IPO.
Class A Common Stock Subject to Possible
Redemption
The Public Shares contain a redemption feature
which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a stockholder
vote or tender offer in connection with the Company’s Initial Business Combination. In accordance with ASC 480-10-S99, the Company
classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control
of the Company. The Public Shares sold as part of the Units in the IPO were issued with other freestanding instruments (i.e., Public Rights),
and as such, the initial carrying value of Public Shares classified as temporary equity is the allocated proceeds determined in accordance
with ASC 470-20. The Company recognizes changes in redemption value immediately as they occurs and will adjust the carrying value of redeemable
shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the IPO, the Company recognized
the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in
charges against additional paid-in capital and retained earnings. Accordingly, at March 31, 2024 and December 31, 2023, Class A common
stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section
of the Company’s condensed balance sheets.
The Company’s Class A common stock features
certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain
future events. Accordingly, as of March 31, 2024 and December 31, 2023, there are 11,500,000 shares of Class A common stock subject to
possible redemption presented as temporary equity, outside of the stockholders’ equity section of the accompanying condensed balance
sheets.
Gross proceeds | |
$ | 115,000,000 | |
Less: | |
| | |
Proceeds allocated to Public Rights | |
| (1,398,400 | ) |
Class A common stock issuance costs | |
| (5,252,889 | ) |
Plus: | |
| | |
Remeasurement of carrying value to redemption value | |
| 10,719,859 | |
Class A Common Stock subject to possible redemption, December 31, 2023 | |
| 119,068,570 | |
Plus: | |
| | |
Remeasurement of carrying value to redemption value | |
| 1,352,668 | |
Class A Common Stock subject to possible redemption, March 31, 2024 | |
$ | 120,421,238 | |
ESH ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2024
(UNAUDITED)
Derivative Financial Instruments
The Company evaluates its equity-linked financial
instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with
ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are classified as liabilities, the derivative
instrument is initially recognized at fair value with subsequent changes in fair value recognized in the statements of operations each
reporting period. The classification of derivative instruments, including whether such instruments should be classified as liabilities
or as equity, is evaluated at the end of each reporting period. The Company accounted for the rights issued in connection with the IPO
and the warrants issued in connection with the Private Placement as equity-classified instruments in accordance with ASC 815 as they did
not meet the liability criteria (i.e., cashless exercises).
Income Taxes
The Company follows the asset and liability method
of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for
the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets
and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply
to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were
deemed de minimis as of March 31, 2024 and December 31, 2023. As of March 31, 2024 and December 31, 2023, the Company’s deferred
tax asset had a full valuation allowance recorded against it. The effective tax rate was 12.5% and 0% for the three months ended March
31, 2024 and 2023, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three months ended March 31,
2024, due to changes in the valuation allowance on the deferred tax assets and prior year true ups from the tax return.
ASC 740 also clarifies the accounting for uncertainty
in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process
for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits
to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. ASC 740 also provides
guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
The Company recognizes accrued interest and penalties
related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest
and penalties as of March 31, 2024 and December 31, 2023. The Company is currently not aware of any issues under review that could result
in significant payments, accruals or material deviation from its position.
The Company has identified the United States
as its only “major” tax jurisdiction. The Company has been subject to income taxation by major taxing authorities since
inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax
jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount
of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) Per Share of Common Stock
The Company has two classes of shares, which
are referred to as Class A common stock and Class B common stock. Earnings and losses are shared pro rata between the two classes of
shares. The Company has not considered the effect of the rights and warrants sold in the IPO and the Private Placement to purchase
an aggregate of 8,620,000 shares of its Class A common stock in the calculation of diluted net income (loss) per share, since their
exercise is contingent upon future events. The following table presents a reconciliation of the numerator and denominator used to
compute basic and diluted net income (loss) per share for each class of common stock:
| |
Three Months Ended March 31, | |
| |
2024 | | |
2023 | |
| |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Basic and Diluted net income (loss) per share | |
| | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| |
Allocation of net income (loss) | |
$ | 915,748 | | |
$ | 223,353 | | |
$ | — | | |
$ | (2,867 | ) |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average shares outstanding | |
| 11,787,500 | | |
| 2,875,000 | | |
| — | | |
| 2,500,000 | |
Basic and diluted net income (loss) per share | |
$ | 0.08 | | |
$ | 0.08 | | |
$ | — | | |
$ | (0.00 | ) |
ESH ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2024
(UNAUDITED)
Recent Accounting Standards
Management does not believe that any recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited
condensed financial statements.
NOTE 3. INITIAL PUBLIC OFFERING
Pursuant to the IPO, the Company sold 11,500,000
Units, which includes the full exercise by the underwriters of their over-allotment option in the amount of 1,500,000 Units, at a price
of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one right. Each Public Right entitles the holder thereof
to receive one-tenth (1/10) of one shares of Class A common stock upon the consummation of the Initial Business Combination.
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the closing of the IPO, the
Sponsor, I-Bankers and Dawson James purchased an aggregate of 7,470,000 Private Placement Warrants, at a price of $1.00 per Private Placement
Warrant, or $7,470,000 in the aggregate, in a private placement.
Each whole Private Placement Warrant is exercisable
for one whole share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement
Warrants to the Sponsor was added to the proceeds from the IPO held in the Trust Account so that the Trust Account holds $10.15 per unit
sold. If the Company does not complete an Initial Business Combination within the Combination Period, the Private Placement Warrants will
expire worthless. The Private Placement Warrants will be redeemable and exercisable on a cashless basis.
The Sponsor and the Company’s officers and
directors have agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30
days after the completion of the Initial business Combination.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On December 17, 2021, the Sponsor subscribed to
purchase 8,625,000 shares of the Company’s Class B common stock, par value $0.0001 per share (the “Founder Shares”)
for a subscription price of $25,000. Such subscription receivable was paid in full on March 9, 2022. On May 8, 2023, the Sponsor surrendered
an aggregate of 5,750,000 shares of its Class B common stock for no consideration, which were cancelled, resulting in the Initial Stockholders
holding an aggregate of 2,875,000 Founder Shares. The Initial Stockholders agreed to forfeit up to 375,000 Founder Shares to the extent
that the over-allotment option was not exercised in full by the underwriters. The forfeiture was to be adjusted to the extent that the
over-allotment option was not exercised in full by the underwriters so that the Founder Shares would represent 20.0% of the Company’s
issued and outstanding shares after the IPO (excluding the Representative Shares). If the Company increased or decreased the size of the
offering, the Company would effect a stock dividend or share contribution back to capital, as applicable, immediately prior to the consummation
of the IPO in such amount as to maintain the Founder Share ownership of the Company’s stockholders prior to the IPO at 20.0% of
the Company’s issued and outstanding common stock upon the consummation of the IPO (excluding the Representative Shares, as defined
below). On June 16, 2023, the underwriters exercised their over-allotment option in full as part of the initial closing of the IPO. As
such, the 375,000 Founder Shares are no longer subject to forfeiture.
ESH ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2024
(UNAUDITED)
The Initial Stockholders have agreed not to transfer,
assign or sell any of their Founder Shares until the earlier to occur of (A) one year after the completion of the Initial Business Combination
or (B) the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction after the Initial Business
Combination that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities
or other property (the “Lock-Up”).
Notwithstanding the foregoing, if the last sale
price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Initial
Business Combination, the Founder Shares will be released from the Lock-Up.
Related Party Loans
Promissory Note to Sponsor
On December 17, 2021 and as amended on May 9,
2023, the Sponsor agreed to loan the Company up to $300,000 pursuant to a promissory note (the “Note”). The Note was
non-interest bearing, unsecured and due upon the earlier of (x) June 30, 2023 (as amended), and (y) the closing of the IPO. The outstanding
balance of $249,560 was repaid at the closing of the IPO on June 16, 2023. As of March 31, 2024 and December 31, 2023, this facility is
no longer available.
Due from Sponsor
At the closing of the IPO on June 16, 2023, a
portion of the proceeds from the sale of the Private Placement Warrants in the amount of $45,440 was due to the Company to be held outside
of the Trust Account for working capital purposes. On June 21, 2023, the Sponsor paid the Company an amount of $30,292 to partially settle
the outstanding balance. In July 2023, the Sponsor paid $13,712 expense reimbursements on behalf of the Company. In October and December
2023, the Company paid a total of $24,360 of Sponsor’s expenses on behalf of the Sponsor. As of March 31, 2024 and December 31,
2023, the Sponsor owes the Company an outstanding amount of $10,136 and $25,796, respectively.
Working Capital Loan
In addition, in order to finance transaction costs
in connection with an Initial Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers
and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If
the Company completes an Initial Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust
Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account.
In the event that an Initial Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account
to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except
for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect
to such loans. The Working Capital Loans would either be repaid upon consummation of an Initial Business Combination, without interest,
or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post
Initial Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants.
As of March 31, 2024 and December 31, 2023, the Company had no borrowings under the Working Capital Loans.
Administrative Services Agreement
The Company entered into an agreement, commencing
on June 13, 2023 through the earlier of consummation of the Initial Business Combination and the Company’s liquidation, to reimburse
an affiliate of the Company’s officers $5,000 per month for office space, utilities, secretarial support and other administrative
and consulting services.
In addition, the Sponsor, executive officers and
directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities
on the Company’s behalf such as identifying potential partner businesses and performing due diligence on suitable Initial Business
Combinations. Any such payments prior to an Initial Business Combination will be made using funds held outside the Trust Account.
For the three months ended March 31, 2024, the
Company incurred and paid $15,000 in fees for these services. For the three months ended March 31, 2023, the Company did not incur any
such fees for these services.
ESH ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2024
(UNAUDITED)
NOTE 6. COMMITMENTS AND CONTINGENCIES
Registration and Stockholder Rights
The holders of Founder Shares, Private Placement
Warrants (and underlying securities) and Private Placement Warrants that may be issued upon conversion of Working Capital Loans (and any
underlying securities) are entitled to registration rights pursuant to a registration rights agreement signed at the consummation of the
IPO. These holders are entitled to certain demand and “piggyback” registration rights. The Company will bear the expenses
incurred in connection with the filing of any such registration statements.
Underwriting Agreement
On June 16, 2023, the Company issued to I-Bankers
258,750 shares of Class A common stock and to Dawson James 28,750 shares of Class A common stock at the closing of the IPO (collectively,
the “Representative Shares”). The Company determined the fair value of the 287,500 Representative Shares to be $2,239,466
(or $7.789 per share) using the Probability-Weighted Expected Return Method Model. The fair value of the shares granted to the
underwriters utilized the following assumptions: (1) expected volatility of 5.7%, (2) risk-free interest rate of 5.15%, (3) expected life
of 1.17 years, and (4) implied discount for lack of marketability of 1.4%. Accordingly, the fair value of $2,239,466 was accounted
for as offering costs at the closing of the IPO.
The Representative Shares have been deemed compensation
by Financial Industry Regulatory Authority (“FINRA”) and are therefore subject to a Lock-Up for a period of 180 days
immediately following the commencement of sales in the IPO. Pursuant to FINRA Rule 5110(e)(1), these securities will not be the subject
of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any
person for a period of 180 days immediately following the commencement of sales in the IPO, nor may they be sold, transferred, assigned,
pledged or hypothecated for a period of 180 days immediately following the commencement of sales in the IPO, except to any underwriters
and selected dealer participating in the offering and their bona fide officers or partners.
The underwriters were also entitled to an underwriting
discount of $0.20 per unit, or $2.3 million in the aggregate, which was paid upon the closing of the IPO.
Initial Business Combination Marketing Agreement
The Company entered into the Marketing Agreement
with the underwriters, I-Bankers and Dawson James to assist the Company in holding meetings with the stockholders to discuss the potential
Initial Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested
in purchasing the Company’s securities in connection with the Initial Business Combination, assist the Company in obtaining stockholder
approval for the Initial Business Combination and assist the Company with its press releases and public filings in connection with the
Initial Business Combination. Pursuant to the Initial Business Combination Marketing Agreement, the Company will pay I-Bankers and Dawson
James, collectively, 3.5% of the gross proceeds of the IPO, or $4.03 million in the aggregate (the “Marketing Fee”).
The Marketing Fee will become payable to I-Bankers and Dawson James from the amounts held in the Trust Account solely in the event that
the Company completes an Initial Business Combination with a target introduced to the Company by I-Bankers.
NOTE 7. STOCKHOLDERS’ EQUITY
Preferred Stock — The Company
is authorized to issue 1,000,000 shares of preferred stock, par value $0.0001 per share, with such designations, voting and other rights
and preferences as may be determined from time to time by the Company’s Board of Directors. At March 31, 2024 and December 31, 2023,
there were no shares of preferred stock issued or outstanding.
Class A Common Stock — The
Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. At March 31, 2024 and
December 31, 2023, there were 287,500 shares of Class A common stock issued and outstanding, excluding 11,500,000 shares of Class A common
stock subject to possible redemption.
Class B Common Stock — The
Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. At March 31, 2024 and
December 31, 2023, there were 2,875,000 shares of Class B common stock issued and outstanding.
ESH ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2024
(UNAUDITED)
Holders of the Class B common stock will have
the right to appoint all of the Company’s directors prior to an Initial Business Combination. On any other matter submitted to a
vote of the Company’s stockholders, holders of the Class A common stock and holders of the Class B common stock will vote together
as a single class, except as required by law or stock exchange rule; provided, that the holders of Class B common stock will be entitled
to vote as a separate class to increase the authorized number of shares of Class B common stock. Each share of common stock will have
one vote on all such matters.
The shares of Class B common stock will automatically
convert into shares of the Company’s Class A common stock at the time of the Company’s Initial Business Combination on a one-for-one
basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further
adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess
of the amounts offered and related to the closing of the Initial Business Combination, the ratio at which shares of Class B common stock
shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class
B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class
A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis,
20% of the sum of the total number of all shares of common stock outstanding upon the completion of the IPO (excluding the Representative
Shares) plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the Initial business
Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the Initial Business Combination,
any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company).
Rights — At March 31, 2024
and December 31, 2023, there were 11,500,000 rights outstanding. Each holder of a right will receive one-tenth (1/10) of a share of Class
A common stock upon consummation of the Initial Business Combination. In the event the Company will not be the survivor upon completion
of the Initial Business Combination, each holder of a right will be required to convert his, her or its rights in order to receive the
1/10 share underlying each right (without paying any additional consideration) upon consummation of the Initial Business Combination.
If the Company is unable to complete an Initial Business Combination within the required time period and it liquidates the funds held
in the Trust Account, holders of rights will not receive any of such funds for their rights and the rights will expire worthless. No fractional
shares will be issued upon conversion of any rights. As a result, a holder must have 10 rights to receive one share of common stock at
the closing of the Initial Business Combination.
Warrants — At March
31, 2024 and December 31, 2023, there were 7,470,000 warrants outstanding. No public warrants were sold in the IPO. The Private Placement
Warrants (including the Class A common stock issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable
or salable until 30 days after the completion of the Initial business Combination.
Each Private Placement Warrant entitles the registered
holder to purchase one share of the Class A common stock at a price of $11.50 per share, at any time commencing on the later of 12 months
from the closing of the IPO or 30 days after the completion of the Initial business Combination. The Private Placement Warrants will expire
five years after the completion of the Initial business Combination, at 5:00 p.m., New York City time, or earlier upon redemption
or liquidation.
The Company has agreed that as soon as practicable,
but in no event later than 15 business days after the closing of the Initial Business Combination, the Company will use its reasonable
best efforts to file, and within 60 business days after the closing the Initial Business Combination, to have declared effective, a registration
statement relating to the shares of Class A common stock issuable upon exercise of the Private Placement Warrants and to maintain
the effectiveness of such registration statement, and a current Prospectus relating to those shares of Class A common stock until
the Private Placement Warrants expire. Notwithstanding the above, if the Company’s shares of Class A common stock are at the
time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered
security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of the Private
Placement Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of
the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement,
but the Company will be required to use its best efforts to qualify the shares under applicable blue sky laws to the extent an exemption
is not available.
ESH ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2024
(UNAUDITED)
Redemption of warrants. Once the Private
Placement Warrants become exercisable, the Company may redeem the outstanding warrants:
| ● | in
whole and not in part; |
| ● | at
a price of $0.01 per warrant; |
| ● | upon
not less than 30 days’ prior written notice of redemption (the “30-day Redemption Period”) to each
warrant holder; and |
| ● | if,
and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock
splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period
ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
The Company may not redeem the Private Placement
Warrants when a holder may not exercise such warrants. The Company has established the last of the redemption criterion discussed above
to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing
conditions are satisfied and the Company issues a notice of redemption of the Private Placement Warrants, each warrant holder will be
entitled to exercise his, her or its warrant prior to the scheduled redemption date. However, the price of the Class A common stock may
fall below the $18.00 redemption trigger price as well as the $11.50 warrant exercise price (for whole shares) after the redemption notice
is issued.
If the Company calls the Private Placement Warrants
for redemption as described above, management will have the option to require any holder that wishes to exercise their warrant to do so
on a “cashless basis”. In determining whether to require all holders to exercise their Private Placement Warrants on a “cashless
basis,” the Company will consider, among other factors, the cash position, the number of Private Placement Warrants that are outstanding
and the dilutive effect on the stockholders of issuing the maximum number of shares of Class A common stock issuable upon the exercise
of the Private Placement Warrants. If the Company takes advantage of this option, all holders of the Private Placement Warrants would
pay the exercise price by surrendering their warrants for that number of shares of Class A common stock equal to the quotient obtained
by dividing (x) the product of the number of shares of Class A common stock underlying the warrants, multiplied by the difference
between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair
market value” shall mean the average reported last sale price of the Class A common stock for the 10 trading days ending on the
third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.
NOTE 8. FAIR VALUE MEASUREMENTS
The fair value of the Company’s financial
assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale
of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the
measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of
observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities).
ESH ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
MARCH 31, 2024
(UNAUDITED)
At March 31, 2024 and December 31, 2023, assets
held in the Trust Account were comprised of $121,565,683 and $120,000,366 in money market funds which are invested primarily in U.S. Treasury
Securities, respectively. Through March 31, 2024, the Company has not withdrawn any income earned from the Trust Account to pay certain
tax obligations.
The following table presents information about
the Company’s assets that are measured at fair value on a recurring basis at March 31, 2024 and December 31, 2023 and indicates
the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
| |
| | |
March 31, | | |
December 31, | |
Description | |
Level | | |
2024 | | |
2023 | |
Assets: | |
| | |
| | |
| |
Investments held in Trust Account – U.S. Treasury Securities Money Market Fund | |
1 | | |
$ | 121,565,683 | | |
$ | 120,000,366 | |
NOTE 9. SUBSEQUENT EVENTS
The Company evaluated subsequent events and
transactions that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements
were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or
disclosure in the unaudited condensed financial statements.
Item 2. Management’s Discussion and Analysis
of Financial Condition and Results of Operations
References in this report (the “Quarterly
Report”) to “we,” “us” or the “Company” refer to ESH Acquisition Corp. References to our
“management” or our “management team” refer to our officers and directors, and references to the “Sponsor”
refer to ESH Sponsor LLC. The following discussion and analysis of the Company’s financial condition and results of operations should
be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information
contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking
statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical
facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All
statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Initial Business Combination
(as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations,
are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,”
“estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking
statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs,
based on information currently available. A number of factors could cause actual events, performance or results to differ materially from
the events, performance and results discussed in the forward-looking statements, including that the conditions of the Initial Business
Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from
those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on
Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings
can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities
law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information,
future events or otherwise.
Overview
We are a blank check company formed under the
laws of the State of Delaware on November 17, 2021 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock
purchase, reorganization or similar business combination with one or more businesses or entities. We intend to effectuate our Initial
Business Combination using cash from the proceeds of the IPO and the sale of the Private Placement Warrants, our capital stock, debt or
a combination of cash, stock and debt.
We expect to continue to incur significant costs
in the pursuit of our acquisition plans. We cannot assure you that our plans to complete an Initial Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor
generated any revenues to date. Our only activities from November 17, 2021 (inception) through March 31, 2024 were organizational activities,
those necessary to prepare for the IPO, described below, and identifying a target company for our Initial Business Combination. We do
not expect to generate any operating revenues until after the completion of our Initial Business Combination. We generate non-operating
income in the form of interest income on investments held in the Trust Account. We incur expenses as a result of being a public company
(for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended March 31, 2024, we
had a net income of $1,139,101, which consists of interest income on investments held in the Trust Account of $1,565,317, offset by operating
costs of $213,567, provision for income taxes of $162,031, and franchise tax expense of $50,618.
For the three months ended March 31, 2023, we
had a net loss of $2,867, which consists of operating costs.
Liquidity and Capital Resources
On June 16, 2023, we consummated the IPO of 11,500,000
Units at $10.00 per Unit, which includes the full exercise by the underwriters of their over-allotment option in the amount of 1,500,000
Units, at $10.00 per Unit, generating gross proceeds of $115,000,000. Simultaneously with the closing of the IPO, we consummated the sale
of 7,470,000 Private Placement Warrants at a price of $1.00 per warrant, in a private placement to the Sponsor and I-Bankers Securities,
Inc. and Dawson James, generating gross proceeds of $7,470,000.
Following the IPO, the full exercise of the over-allotment
option, and the sale of the Private Placement Warrants, a total of $116,725,000 ($10.15 per Unit) was placed in the Trust Account. We
incurred $5,368,092 in IPO related costs, consisting of $2,300,000 of cash underwriting discount, $2,239,466 fair value of Representative
Shares, and $828,626 of other offering costs.
For the three months ended March 31, 2024, cash
provided by operating activities was $20,103. Net income of $1,139,101 was affected by interest earned on investments held in the Trust
Account of $1,565,317. Changes in operating assets and liabilities provided $446,319 of cash for operating activities.
For the three months ended March 31, 2023, cash
used in operating activities was $5,718. Net loss of $2,867 was affected by changes in operating assets and liabilities which used $2,851
of cash for operating activities.
As of March 31, 2024, we had investments held
in the Trust Account of $121,565,683 (including $4,840,683 of interest income) consisting of U.S. Treasury securities. Interest income
on the balance in the Trust Account may be used by us to pay taxes. Through March 31, 2024, we have not withdrawn any interest earned
from the Trust Account.
We intend to use substantially all of the funds
held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete
our Initial Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete
our Initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations
of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of March 31, 2024, we had cash of $1,820,447.
We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence
on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their
representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate
and complete our Initial Business Combination.
In order to fund working capital deficiencies
or finance transaction costs in connection with our Initial Business Combination, the Sponsor, or certain of our officers and directors
or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete our Initial Business Combination,
we would repay such loaned amounts. In the event that our Initial Business Combination does not close, we may use a portion of the working
capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment.
Up to $1,500,000 of such loans may be convertible into warrants at a price of $1.00 per warrant, at the option of the lender. The warrants
would be identical to the Private Placement Warrants.
We do not believe we will need to raise additional
funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target
business, undertaking in-depth due diligence and negotiating our Initial Business Combination are less than the actual amount necessary
to do so, we may have insufficient funds available to operate our business prior to our Initial Business Combination. Moreover, we may
need to obtain additional financing either to complete our Initial Business Combination or because we become obligated to redeem a significant
number of our Public Shares upon consummation of our Initial Business Combination, in which case we may issue additional securities or
incur debt in connection with such Initial Business Combination.
We have determined that mandatory liquidation,
should a business combination not occur by December 16, 2024, and potential subsequent dissolution raise substantial doubt about our ability
to continue as a going concern for a reasonable period of time which is considered to be one year from the date of the issuance of the
financial statements. The financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification
of the liabilities that might be necessary should we be unable to continue as a going concern.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities,
which would be considered off-balance sheet arrangements as of March 31, 2024. We do not participate in transactions that create relationships
with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established
for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual Obligations
We do not have any long-term debt, capital lease
obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of one of our officers
a monthly fee of $5,000 for office space, utilities, secretarial support and other administrative and consulting services. We began incurring
these fees on June 13, 2023 and will continue to incur these fees monthly until the earlier of the completion of the Initial Business
Combination and our liquidation.
In addition, the Sponsor, executive officers and
directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities
on the Company’s behalf such as identifying potential partner businesses and performing due diligence on suitable Initial Business
Combinations. Any such payments prior to an Initial Business Combination will be made using funds held outside the Trust Account.
The underwriters were entitled to an underwriting
discount of $0.20 per unit, or $2.3 million in the aggregate, which was paid upon the closing of the IPO.
We entered into an Initial Business Combination
marketing agreement (the “Marketing Agreement”) with the underwriters, I-Bankers and Dawson James, to assist us in
holding meetings with the stockholders to discuss the potential Initial Business Combination and the target business’ attributes,
introduce us to potential investors that are interested in purchasing our securities in connection with the Initial Business Combination,
assist us in obtaining stockholder approval for the Initial Business Combination and assist us with its press releases and public filings
in connection with the Initial Business Combination. Pursuant to the Marketing Agreement, we will pay I-Bankers and Dawson James, collectively,
3.5% of the gross proceeds of the IPO, or $4.03 million in the aggregate (the “Marketing Fee”). The Marketing Fee will
become payable to I-Bankers and Dawson James from the amounts held in the Trust Account solely in the event that we complete an Initial
Business Combination with a target introduced to us by I-Bankers.
Critical Accounting Policies and Estimates
The preparation of unaudited condensed financial statements
and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities
at the date of the unaudited condensed financial statements, and income and expenses during the periods reported. Actual results could
materially differ from those estimates. As of March 31, 2024, we have not identified any critical accounting policies, while we have identified
a critical accounting estimate below:
Class A Common Stock Subject to Possible Redemption
We account for our Class A common stock subject
to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing
Liabilities from Equity.” Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured
at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are within the control
of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified in temporary
equity. At all other times, common stock is classified as stockholders’ equity. Our Class A common stock features certain redemption
rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, at March 31,
2024 and December 31, 2023, 11,500,000 shares of Class A common stock are presented at redemption value as temporary equity, outside of
the stockholders’ equity section of our balance sheets. As of March 31, 2024 and December 31, 2023, Class A common stock subject
to possible redemption amounts to $120,421,238 and $119,068,570, respectively.
Recent Accounting Standards
Management does not believe that any recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our unaudited condensed financial
statements.
Item 3. Quantitative and Qualitative Disclosures
About Market Risk
Not required for smaller reporting companies.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed
to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported
within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our
management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate
to allow timely decisions regarding required disclosure.
Under the supervision and with the participation
of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation
of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended March 31, 2024, as such term
is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal
financial and accounting officer have concluded that during the period covered by this report, our disclosure controls and procedures
were effective at a reasonable assurance level and, accordingly, provided reasonable assurance that the information required to be disclosed
by us in reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the
SEC’s rules and forms.
Changes in Internal Control over Financial
Reporting
There was no change in our internal control over
financial reporting that occurred during the fiscal quarter of 2024 covered by this Quarterly Report on Form 10-Q that has materially
affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
None
Item 1A. Risk Factors
Factors that could cause our actual results to
differ materially from those in this report include the risk factors described in our Annual Report on Form 10-K filed with the SEC. As
of the date of this Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed
with the SEC.
Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds.
On June 16, 2023, we consummated the Initial Public
Offering of 11,500,000 Units, which includes the full exercise by the underwriters of their over-allotment option in the amount of 1,500,000
Units, at $10.00 per Unit, generating total gross proceeds of $115,000,000. I-Bankers Securities, Inc and IB Capital LLC acted as joint
book-running managers, with Dawson James Securities, Inc. acting as co-manager of the Initial Public Offering. The securities in the offering
were registered under the Securities Act on registration statement on Form S-1 (No. 333-265226). The Securities and Exchange Commission
declared the registration statements effective on June 13, 2023.
Simultaneous with the consummation of the Initial
Public Offering, the Sponsor, I-Bankers Securities, Inc. and Dawson James, consummated the private placement warrants of an aggregate
of 7,470,000 warrants at a price of $1.00 per warrant, generating total proceeds of $7,470,000. Each Unit consists of one share of Class
A common stock and one right. Each whole Private Placement Warrant is exercisable for one whole share of Class A common stock at a price
of $11.50 per share. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities
Act.
Of the gross proceeds received from the Initial
Public Offering, the full exercise of the over-allotment option and the Private Placement Warrants, an aggregate of $116,725,000 was placed
in the Trust Account.
We incurred transaction costs amounting to $5,368,092
consisting of $2,300,000 of cash underwriting discount, $2,239,466 fair value of representative shares, and $828,626 of other offering
costs.
For a description of the use of the proceeds generated
in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q.
Item 3. Defaults Upon Senior Securities
None
Item 4. Mine Safety Disclosures
None
Item 5. Other Information
During the three months ended March 31, 2024,
no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (in
each case, as defined in Item 408(a) of Regulation-S-K).
Item 6. Exhibits
The following exhibits are filed as part of, or
incorporated by reference into, this Quarterly Report on Form 10-Q.
No. |
|
Description of Exhibit |
1.1 |
|
Underwriting Agreement, dated June 13, 2023, by and among the Company, I-Bankers and Dawson James.(1) |
1.2 |
|
Business Combination Marketing Agreement, dated June 13, 2023, by and among the Company, I-Bankers and Dawson James Securities, Inc. (1) |
3.1 |
|
Amended and Restated Certificate of Incorporation(1) |
3.2 |
|
By-Laws of ESH Acquisition Corp.(2) |
4.1 |
|
Rights Agreement, dated June 13, 2023, by and between the Company and CST(1) |
4.2 |
|
Warrant Agreement, dated June 13, 2023, by and between CST and the Company. (1) |
10.1 |
|
Investment Management Trust Agreement, dated June 13, 2023, by and between CST and the Company. (1) |
10.2 |
|
Registration and Rights Agreement, dated June 13, 2023, by and among the Company, the Sponsor, I-Bankers and Dawson James. (1) |
10.3 |
|
Private Placement Warrants Purchase Agreement, dated June 13, 2023, by and among the Company, the Sponsor, I-Bankers and Dawson James. (1) |
10.4 |
|
Indemnity Agreement, dated June 13, 2023, by and between the Company and James Franics. (1) |
10.5 |
|
Indemnity Agreement, dated June 13, 2023, by and between the Company and Jonathan Morris. (1) |
10.6 |
|
Indemnity Agreement, dated June 13, 2023, by and between the Company and Thomas Wolber. (1) |
10.7 |
|
Indemnity Agreement, dated June 13, 2023, by and between the Company and Jonathan Gordon. (1) |
10.8 |
|
Indemnity Agreement, dated June 13, 2023, by and between the Company and Christina Francis. (1) |
10.9 |
|
Indemnity Agreement, dated June 13, 2023, by and between the Company and Christopher Ackerley. (1) |
10.10 |
|
Indemnity Agreement, dated June 13, 2023, by and between the Company and Allen Weiss. (1) |
10.11 |
|
Administrative Services Agreement, dated June 13, 2023, between the Company and the Sponsor. (1) |
10.12 |
|
Letter Agreement, dated June 13, 2023, by and among the Company, the Sponsor, I-Bankers, Dawson James and the Company’s officers and directors. (1) |
31.1* |
|
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
31.2* |
|
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
32.1* |
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
32.2* |
|
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
101.INS* |
|
Inline XBRL Instance Document |
101.SCH* |
|
Inline XBRL Taxonomy Extension Schema Document |
101.CAL* |
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document |
101.DEF* |
|
Inline XBRL Taxonomy Extension Definition Linkbase Document |
101.LAB* |
|
Inline XBRL Taxonomy Extension Labels Linkbase Document |
101.PRE* |
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document |
104 |
|
Cover Page Interactive Data File |
(1) | Previously filed as an exhibit to our Current Report on Form
8-K filed on June 20, 2023 and incorporated by reference herein. |
(2) | Previously filed as an exhibit to our Quarterly Report on
Form 10-Q filed on November 14, 2023 and incorporated by reference herein. |
SIGNATURES
In accordance with the requirements
of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
ESH
Acquisition Corp. |
|
|
|
Date: May 20,
2024 |
By: |
/s/
James Francis |
|
Name: |
James Francis |
|
Title: |
Chief Executive Officer |
|
|
(Principal Executive Officer) |
|
|
|
Date: May 20,
2024 |
By: |
/s/ Jonathan Morris |
|
Name: |
Jonathan Morris |
|
Title: |
Chief Financial Officer |
|
|
(Principal Financial and Accounting Officer) |
11787500
0.08
2500000
2875000
0.00
0.08
11787500
2500000
2875000
0.00
0.08
0.08
P5Y
false
--12-31
Q1
0001918661
0001918661
2024-01-01
2024-03-31
0001918661
eshau:UnitsMember
2024-01-01
2024-03-31
0001918661
eshau:ClassASharesMember
2024-01-01
2024-03-31
0001918661
eshau:RightMember
2024-01-01
2024-03-31
0001918661
us-gaap:CommonClassAMember
2024-05-20
0001918661
us-gaap:CommonClassBMember
2024-05-20
0001918661
2024-03-31
0001918661
2023-12-31
0001918661
eshau:SponsorMember
2024-03-31
0001918661
eshau:SponsorMember
2023-12-31
0001918661
us-gaap:CommonClassAMember
2024-03-31
0001918661
us-gaap:CommonClassAMember
2023-12-31
0001918661
us-gaap:CommonClassBMember
2024-03-31
0001918661
us-gaap:CommonClassBMember
2023-12-31
0001918661
2023-01-01
2023-03-31
0001918661
us-gaap:CommonClassAMember
2024-01-01
2024-03-31
0001918661
us-gaap:CommonClassAMember
2023-01-01
2023-03-31
0001918661
us-gaap:CommonClassBMember
2024-01-01
2024-03-31
0001918661
us-gaap:CommonClassBMember
2023-01-01
2023-03-31
0001918661
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-12-31
0001918661
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-12-31
0001918661
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001918661
us-gaap:RetainedEarningsMember
2023-12-31
0001918661
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2024-01-01
2024-03-31
0001918661
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2024-01-01
2024-03-31
0001918661
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-03-31
0001918661
us-gaap:RetainedEarningsMember
2024-01-01
2024-03-31
0001918661
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2024-03-31
0001918661
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2024-03-31
0001918661
us-gaap:AdditionalPaidInCapitalMember
2024-03-31
0001918661
us-gaap:RetainedEarningsMember
2024-03-31
0001918661
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-12-31
0001918661
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-12-31
0001918661
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001918661
us-gaap:RetainedEarningsMember
2022-12-31
0001918661
2022-12-31
0001918661
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001918661
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001918661
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-03-31
0001918661
us-gaap:RetainedEarningsMember
2023-01-01
2023-03-31
0001918661
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-03-31
0001918661
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-03-31
0001918661
us-gaap:AdditionalPaidInCapitalMember
2023-03-31
0001918661
us-gaap:RetainedEarningsMember
2023-03-31
0001918661
2023-03-31
0001918661
us-gaap:IPOMember
2023-06-16
0001918661
us-gaap:OverAllotmentOptionMember
2023-06-16
0001918661
us-gaap:OverAllotmentOptionMember
2023-06-16
2023-06-16
0001918661
us-gaap:WarrantMember
us-gaap:PrivatePlacementMember
2024-01-01
2024-03-31
0001918661
us-gaap:WarrantMember
us-gaap:PrivatePlacementMember
2024-03-31
0001918661
us-gaap:IPOMember
2024-01-01
2024-03-31
0001918661
us-gaap:IPOMember
2023-06-16
2023-06-16
0001918661
eshau:PublicShareMember
2024-03-31
0001918661
us-gaap:IPOMember
2024-03-31
0001918661
eshau:TrustAccountMember
2024-01-01
2024-03-31
0001918661
2023-01-01
2023-12-31
0001918661
us-gaap:OverAllotmentOptionMember
2024-01-01
2024-03-31
0001918661
us-gaap:PrivatePlacementMember
2024-03-31
0001918661
us-gaap:PrivatePlacementMember
2024-01-01
2024-03-31
0001918661
us-gaap:CommonClassAMember
us-gaap:PrivatePlacementMember
2024-03-31
0001918661
eshau:FounderSharesMember
us-gaap:CommonClassBMember
2021-12-17
2021-12-17
0001918661
eshau:FounderSharesMember
us-gaap:CommonClassBMember
2021-12-17
0001918661
2021-12-17
2021-12-17
0001918661
2023-05-01
2023-05-08
0001918661
eshau:FounderSharesMember
us-gaap:OverAllotmentOptionMember
2023-05-01
2023-05-08
0001918661
eshau:UnderwritersMember
2023-05-08
0001918661
eshau:FounderSharesMember
2023-05-08
0001918661
eshau:FounderSharesMember
2023-06-16
2023-06-16
0001918661
eshau:SponsorMember
2021-12-17
0001918661
eshau:PromissoryNoteMember
2023-06-16
2023-06-16
0001918661
eshau:SponsorMember
eshau:PrivatePlacementWarrantsMember
2023-06-16
2023-06-16
0001918661
eshau:SponsorMember
2023-06-21
0001918661
2023-07-31
2023-07-31
0001918661
eshau:SponsorMember
2024-01-01
2024-03-31
0001918661
eshau:SponsorMember
2023-01-01
2023-12-31
0001918661
us-gaap:RelatedPartyMember
2024-03-31
0001918661
us-gaap:RelatedPartyMember
2023-12-31
0001918661
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2024-03-31
0001918661
2023-06-13
2023-06-13
0001918661
eshau:CustomIbankersMember
2023-06-16
2023-06-16
0001918661
eshau:DawsonJamesMember
2023-06-16
2023-06-16
0001918661
2023-06-16
2023-06-16
0001918661
2023-06-16
0001918661
us-gaap:RightsMember
2024-03-31
0001918661
us-gaap:RightsMember
2022-12-31
0001918661
us-gaap:WarrantMember
2023-12-31
0001918661
us-gaap:WarrantMember
2024-03-31
0001918661
us-gaap:CommonClassAMember
eshau:PrivatePlacementWarrantsMember
2024-01-01
2024-03-31
0001918661
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2024-03-31
0001918661
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
In connection with the Quarterly Report of ESH
Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2024, as filed with the Securities
and Exchange Commission (the “Report”), I, James Francis, Chief Executive Officer of the Company, certify, pursuant
to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
In connection with the Quarterly Report of ESH
Acquisition Corp. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2024, as filed with the Securities
and Exchange Commission (the “Report”), I, Jonathan Morris, Chief Financial Officer of the Company, certify, pursuant
to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge: